See more : FibroGen, Inc. (FGEN) Income Statement Analysis – Financial Results
Complete financial analysis of Finolex Industries Limited (FINOLEXIND.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Finolex Industries Limited, a leading company in the industry within the sector.
- Medigene AG (0QGJ.L) Income Statement Analysis – Financial Results
- Nordrest Holding AB (NREST.ST) Income Statement Analysis – Financial Results
- Conagra Brands, Inc. (CAG) Income Statement Analysis – Financial Results
- Raksul Inc. (RKSLF) Income Statement Analysis – Financial Results
- Ganon Products Limited (GANONPRO.BO) Income Statement Analysis – Financial Results
Finolex Industries Limited (FINOLEXIND.BO)
Industry: Construction Materials
Sector: Industrials
About Finolex Industries Limited
Finolex Industries Limited manufactures and sells polyvinyl chloride (PVC) pipes and fittings, and PVC resins in India. It operates in two segments, PVC Resin and PVC Pipes and Fittings. The company offers agriculture pipes and fittings; column pipes; casing pipes; solvent cement and lubricants; ASTM plumbing pipes and fittings; chlorinated PVC pipes and fittings; SWR pipes and fittings; sewerage pipes; and solvent cement lubricant and primer. It distributes its products through dealers and retail outlets. The company was founded in 1956 and is headquartered in Pune, India.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 43.84B | 46.37B | 34.53B | 29.78B | 30.86B |
| Cost of Revenue | 39.25B | 35.25B | 24.25B | 24.50B | 24.13B |
| Gross Profit | 4.60B | 11.12B | 10.28B | 5.28B | 6.73B |
| Gross Profit Ratio | 10.49% | 23.98% | 29.78% | 17.74% | 21.81% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.05B | 1.50B | 1.03B | 1.11B | 1.22B |
| Other Expenses | -85.80M | -91.40M | -130.40M | -106.10M | -122.30M |
| Operating Expenses | 2.14B | 1.59B | 1.16B | 1.22B | 1.34B |
| Cost & Expenses | 41.38B | 36.84B | 25.41B | 25.72B | 25.47B |
| Interest Income | 295.20M | 374.20M | 335.70M | 81.70M | 83.90M |
| Interest Expense | 131.40M | 35.60M | 94.20M | 47.80M | 77.20M |
| Depreciation & Amortization | -892.00M | -834.00M | -777.20M | -738.10M | -700.80M |
| EBITDA | 3.35B | 10.36B | 9.90B | 4.80B | 6.09B |
| EBITDA Ratio | 7.65% | 22.34% | 28.67% | 16.12% | 19.73% |
| Operating Income | 2.46B | 9.53B | 9.12B | 4.06B | 5.39B |
| Operating Income Ratio | 5.61% | 20.55% | 26.41% | 13.65% | 17.46% |
| Total Other Income/Expenses | 509.30M | 4.32B | 637.10M | -141.30M | -41.80M |
| Income Before Tax | 2.97B | 13.85B | 9.76B | 3.92B | 5.34B |
| Income Before Tax Ratio | 6.77% | 29.86% | 28.26% | 13.17% | 17.32% |
| Income Tax Expense | 705.90M | 3.32B | 2.54B | 851.70M | 1.81B |
| Net Income | 2.51B | 10.51B | 7.38B | 3.33B | 3.67B |
| Net Income Ratio | 5.72% | 22.67% | 21.37% | 11.17% | 11.90% |
| EPS | 4.05 | 16.94 | 2.38 | 5.38 | 5.92 |
| EPS Diluted | 4.05 | 16.94 | 2.38 | 5.38 | 5.92 |
| Weighted Avg Shares Out | 618.31M | 620.48M | 3.10B | 618.31M | 620.50M |
| Weighted Avg Shares Out (Dil) | 618.31M | 620.48M | 3.10B | 618.31M | 620.50M |
Source: https://incomestatements.info
Category: Stock Reports